Free Trial

Aimei Health Technology (AFJK) Competitors

Aimei Health Technology logo
$10.90 0.00 (0.00%)
As of 02/20/2025

AFJK vs. LAND, PKST, RRAC, MBAV, IPXX, BIOX, BACQ, GIG, BRT, and UROY

Should you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include Gladstone Land (LAND), Peakstone Realty Trust (PKST), Rigel Resource Acquisition (RRAC), M3-Brigade Acquisition V (MBAV), Inflection Point Acquisition Corp. II (IPXX), Bioceres Crop Solutions (BIOX), Bleichroeder Acquisition Corp I - Class A (BACQ), Gigcapital7 (GIG), BRT Apartments (BRT), and Uranium Royalty (UROY). These companies are all part of the "trading" industry.

Aimei Health Technology vs.

Aimei Health Technology (NASDAQ:AFJK) and Gladstone Land (NASDAQ:LAND) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Gladstone Land had 9 more articles in the media than Aimei Health Technology. MarketBeat recorded 9 mentions for Gladstone Land and 0 mentions for Aimei Health Technology. Gladstone Land's average media sentiment score of 0.71 beat Aimei Health Technology's score of 0.00 indicating that Gladstone Land is being referred to more favorably in the news media.

Company Overall Sentiment
Aimei Health Technology Neutral
Gladstone Land Positive

Gladstone Land has a consensus target price of $15.50, suggesting a potential upside of 39.64%. Given Gladstone Land's stronger consensus rating and higher probable upside, analysts plainly believe Gladstone Land is more favorable than Aimei Health Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Gladstone Land
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Gladstone Land has a net margin of 15.59% compared to Aimei Health Technology's net margin of 0.00%. Gladstone Land's return on equity of 1.88% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A N/A N/A
Gladstone Land 15.59%1.88%0.99%

45.6% of Aimei Health Technology shares are owned by institutional investors. Comparatively, 53.6% of Gladstone Land shares are owned by institutional investors. 1.7% of Aimei Health Technology shares are owned by company insiders. Comparatively, 7.2% of Gladstone Land shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Gladstone Land has higher revenue and earnings than Aimei Health Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$170KN/AN/A
Gladstone Land$85.22M4.71$14.56M-$0.29-38.27

Gladstone Land received 360 more outperform votes than Aimei Health Technology when rated by MarketBeat users.

CompanyUnderperformOutperform
Aimei Health TechnologyN/AN/A
Gladstone LandOutperform Votes
360
69.50%
Underperform Votes
158
30.50%

Summary

Gladstone Land beats Aimei Health Technology on 13 of the 13 factors compared between the two stocks.

Get Aimei Health Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFJK vs. The Competition

MetricAimei Health TechnologyHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$98.43M$473.76M$129.52M$8.98B
Dividend YieldN/A6.96%N/A3.85%
P/E RatioN/A2.271.2318.82
Price / SalesN/A91.5011.7880.40
Price / Cash500.2069.1394.0337.47
Price / Book-545.004.111.054.64
Net Income$170,000.00$35.22M$1.63M$245.69M
7 Day PerformanceN/A-0.61%-0.27%-2.66%
1 Month Performance0.94%-4.59%-1.03%-2.15%
1 Year Performance7.07%24.09%30.23%12.90%

Aimei Health Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFJK
Aimei Health Technology
N/A$10.90
flat
N/A+7.1%$98.43MN/A0.00N/ANews Coverage
LAND
Gladstone Land
3.7945 of 5 stars
$11.62
-0.4%
$15.50
+33.4%
-15.6%$392.60M$90.40M0.0070Earnings Report
News Coverage
PKST
Peakstone Realty Trust
3.261 of 5 stars
$10.84
-0.3%
$15.00
+38.4%
-24.2%$388.93M$254.28M0.0035Earnings Report
Dividend Announcement
News Coverage
Positive News
Gap Up
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
MBAV
M3-Brigade Acquisition V
N/A$10.16
+0.1%
N/AN/A$364.24MN/A0.00N/ANews Coverage
IPXX
Inflection Point Acquisition Corp. II
N/A$11.51
+0.1%
N/A+5.5%$359.66MN/A0.00N/ANews Coverage
Positive News
BIOX
Bioceres Crop Solutions
2.5054 of 5 stars
$4.96
+4.6%
$9.88
+99.1%
-64.5%$349.93M$464.80M248.12500High Trading Volume
BACQ
Bleichroeder Acquisition Corp I - Class A
N/A$9.95
-0.1%
N/AN/A$335.91MN/A0.00N/A
GIG
Gigcapital7
N/A$10.06
-0.1%
N/AN/A$335.30MN/A0.00N/AHigh Trading Volume
BRT
BRT Apartments
3.6731 of 5 stars
$17.68
-1.3%
$23.00
+30.1%
+8.7%$332.40M$95.17M-33.359News Coverage
UROY
Uranium Royalty
1.7334 of 5 stars
$2.21
-5.2%
$5.60
+153.4%
-24.0%$328.64M$31.62M73.6910Positive News

Related Companies and Tools


This page (NASDAQ:AFJK) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners